P-148 - Peptides
Marriott Regents Park Hotel, London, UK (July, 8 - 9, 2015)
The conference sets the stage for attendees to gain valuable insight into innovative topics such as cyclic peptides: R&D platforms, manufacture and stability, oral delivery of peptides, cell permeable peptide therapeutics for cancer treatments and Development of Peptides for the Clinic. Along with this, the programme will provide insight into formulating solutions for delivery and round table discussions on case studies demonstrating the translation of R&D peptides to the clinic.
Reasons why you should attend:
- ENHANCE understandings of current peptide R&D platforms to allow for rapid and efficient discovery of new compounds.
- GAIN a greater insight into oral delivery mechanisms to allow for greater access to the clinic and increased patient compliance.
- LEARN how to translate R&D from the bench to the clinic to ensure smooth transitions.
- EXPAND Familiarity about current peptide synthesis mechanisms and gain an insight into what technologies are available to synthesise peptides in an effective manner.
- DEVELOP knowledge on the latest breakthrough peptide therapeutics and first in class drugs to treat non-communicable diseases.
Keynote speakers include:
- Lutz Jermutus, Senior Director, R&D & Product Development Team Leader,
MedImmune - Jörg vollmer, CEO, Nexigen
- Stephen Hale, SVP Biological Sciences, Ensemble Therapeutics
- Dan Teufel, Head of Chemistry, Bicycle Therapeutics
- Juan J. diaz-Mochon, Group Leader NANOCHEMBIO research team, Genyo
- Renata Zbozien, Research Manager, Haemostatix
In addition, don't miss the half day pre-conference workshop taking place on the 7th July:
- Cyclic Peptides: Discovery, Development and Deployment
Workshop Leaders: Roger new, CSO, Diabetology
Book before 31st March to save ?400
Register online at http://www.smi-online.co.uk/2015peptides4.asp
Contact Magdalena Georgieva on +44 (0)20 7827 6148 or email mgeorgieva@smi-online.co.uk
